New combo therapy trial aims to fight tough sarcomas

NCT ID NCT07342322

Summary

This study is testing a new combination treatment for people with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The treatment mixes a specialized form of radiation with several immunotherapy drugs. Researchers want to see if this approach is safe and can help control the cancer. About 25 adults with certain types of sarcoma will receive the year-long treatment and be closely monitored.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA (STS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • the First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, 530021, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.